Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Weight Gain and OPRM1[original query] |
---|
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. The pharmacogenomics journal 2004 4 (3): 184-92. Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH |
Association of the mu-opioid receptor gene with smoking cessation. The pharmacogenomics journal 2007 Oct 7 (5): 353-61. Munafò M R, Elliot K M, Murphy M F G, Walton R T, Johnstone E |
Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. Alcohol and alcoholism (Oxford, Oxfordshire) 2019 Jun . Roche Daniel J O, Trela Constantine J, Argos Maria, Jasmine Farzana, Kibriya Muhammad G, Ahsan Habibul, King Andrea |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: